Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A D Ogilvie

Showing results (1-10 of 16) with videos related to

Pageof 2
Sort By:
BMJ (Clinical Research Ed.)|June 28, 1997
Colombia is confused over legalisation of euthanasiaA D Ogilvie
Lancet (London, England)|December 4, 1993
Hair loss during fluoxetine treatmentA D Ogilvie
Lancet (London, England)|September 12, 1992
Clozapine and hyponatraemiaA D Ogilvie, M F Croy
Molecular Medicine (Cambridge, Mass.)|February 1, 1997
Association between the serotonin transporter gene and affective disorder: the evidence so farA D Ogilvie, A J Harmar
Trends in Neurosciences|November 1, 1996
Function and dysfunction in the nervous systemA J Harmar, A D Ogilvie
BMJ (Clinical Research Ed.)|August 20, 1994
Assisted suicide for depression: the slippery slope in action?A D Ogilvie, S G Potts
Psychological Medicine|December 24, 1997
Clinical and psychometric correlates of dopamine D2 binding in depressionP J Shah, A D Ogilvie, G M Goodwin, et al.
Annals of the Rheumatic Diseases|June 1, 1990
In situ hybridisationA D Ogilvie, N C Wood, E Dickens, et al.
Psychopharmacology|January 18, 2002
Improved short-term spatial memory but impaired reversal learning following the dopamine D(2) agonist bromocriptine in human volunteersM A Mehta, R Swainson, A D Ogilvie, et al.
Lancet (London, England)|March 16, 1996
Polymorphism in serotonin transporter gene associated with susceptibility to major depressionA D Ogilvie, S Battersby, V J Bubb, et al.
Pageof 2

Showing results (1-10 of 16) with videos related to

Sort By:
Pageof 2
BMJ (Clinical Research Ed.)|June 28, 1997
Colombia is confused over legalisation of euthanasiaA D Ogilvie
Lancet (London, England)|December 4, 1993
Hair loss during fluoxetine treatmentA D Ogilvie
Lancet (London, England)|September 12, 1992
Clozapine and hyponatraemiaA D Ogilvie, M F Croy
Molecular Medicine (Cambridge, Mass.)|February 1, 1997
Association between the serotonin transporter gene and affective disorder: the evidence so farA D Ogilvie, A J Harmar
Trends in Neurosciences|November 1, 1996
Function and dysfunction in the nervous systemA J Harmar, A D Ogilvie
BMJ (Clinical Research Ed.)|August 20, 1994
Assisted suicide for depression: the slippery slope in action?A D Ogilvie, S G Potts
Psychological Medicine|December 24, 1997
Clinical and psychometric correlates of dopamine D2 binding in depressionP J Shah, A D Ogilvie, G M Goodwin, et al.
Annals of the Rheumatic Diseases|June 1, 1990
In situ hybridisationA D Ogilvie, N C Wood, E Dickens, et al.
Psychopharmacology|January 18, 2002
Improved short-term spatial memory but impaired reversal learning following the dopamine D(2) agonist bromocriptine in human volunteersM A Mehta, R Swainson, A D Ogilvie, et al.
Lancet (London, England)|March 16, 1996
Polymorphism in serotonin transporter gene associated with susceptibility to major depressionA D Ogilvie, S Battersby, V J Bubb, et al.
Pageof 2